Choice of control group in efficacy-showing clinical trials in Japan: does the ICH-E10 guideline change conventions?

Author： Shunsuke O. Taro S. Toshihiko M. Hiroyuki U. Toshihiko N.

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.16, Iss.2, 2002-04, pp. : 79-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials in Japan After Implementation of the International Conference on Harmonization Good Clinical Practice (ICH-GCP) Guidelines: Increasing Westernization?

By Ono S.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 2, 2003-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Does guideline adherence improve antibacterial therapy?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Are clinical trials worth it to insurers?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Design of Clinical Trials of Antidepressants: Should a Placebo Control Arm be Included?

By Fritze J.

CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

Clinical Trials and the New Good Clinical Practice Guideline in Japan: An Economic Perspective

By Ono S.

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 125-141

Adis International

Access to resources Recommend Favorite